Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05630014 · ClinicalTrials.gov registry record · NA

Study of the Aliviado DSD Caregiving Mastery Program

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
33
Enrollment target

NCT05630014 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 33 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05630014, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target

Study Summary

Delirium superimposed on dementia (DSD) is an acute and serious condition that is common in persons living with dementia (PLWD). Involvement of family caregivers may aid prevention, early detection, and management of DSD. The purpose of the proposed study is two-fold. First, the investigators will develop a family-centered, mHealth-enhanced DSD caregiving mastery program ("Aliviado DSD Caregiving Mastery Program") through a 5-week co-design workshop with 8 family caregivers (Aim 1). The investigators will adapt/refine the existing clinician-centered DSD contents and an mHealth app from the evidence-based "Aliviado Dementia Care" program for use by family caregivers to support their day-to-day implementation of DSD detection, prevention, and management tasks in the community. Second, the investigators will pilot test the full Aliviado DSD Caregiving Mastery Program with family caregivers of PLWD at high risk for delirium, assessing feasibility, acceptability, app usability, and preliminary program impact (Aim 2).

Interventions

  • BEHAVIORAL Aliviado DSD Caregiving Mastery Program

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2023-12-20
Est. Completion 2025-02-11
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT05630014

The ClinicalTrials.gov registry entry for NCT05630014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Aliviado DSD Caregiving Mastery Program is the first listed.

NCT05630014 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05630014 about?

NCT05630014 is a clinical study titled "Study of the Aliviado DSD Caregiving Mastery Program". Delirium superimposed on dementia (DSD) is an acute and serious condition that is common in persons living with dementia (PLWD). Involvement of family caregivers may aid prevention, early detection, and management of DSD. The purpose of the proposed study is two-fold. First, the investigators will d...

What is the current status of trial NCT05630014?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2023-12-20. Estimated completion is 2025-02-11.

What interventions are being tested in trial NCT05630014?

The interventions under investigation include: Aliviado DSD Caregiving Mastery Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT05630014?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.